Table 1 Clinicopathological characteristics of training and validation cohort
From: Immune-related lncRNA classification of head and neck squamous cell carcinoma
Variable | Training cohort | Validation cohort |
|---|---|---|
Age | Â | Â |
 < 60 | 153 (44.61%) | 65 (44.22%) |
 >=60 | 190 (55.39%) | 82 (55.78%) |
Gender | Â | Â |
 Female | 94 (27.41%) | 35 (23.81%) |
 Male | 249 (72.59%) | 112 (76.19%) |
Race | Â | Â |
 White | 291 (84.84%) | 129 (87.76%) |
 Others | 42 (12.24%) | 14 (9.52%) |
 Unknown | 10 (2.92%) | 4 (2.72%) |
Alcohol consumption | Â | |
 No | 103 (30.03%) | 48 (32.65%) |
 Yes | 235 (68.51%) | 93 (63.27%) |
 Unknown | 5 (1.46%) | 6 (4.08%) |
Histologic grade | Â | |
 G1+G2 | 255 (74.34%) | 97 (65.99%) |
 G3+G4 | 79 (23.03%) | 40 (27.21%) |
 Unknown | 9 (2.62%) | 10 (6.80%) |
Stage | Â | Â |
 Stage I+II | 61 (17.78%) | 33 (22.45%) |
 Stage III +IV | 233 (67.93%) | 96 (65.31%) |
 Unknown | 49 (14.29%) | 18 (12.24%) |
Vital status | Â | Â |
 Alive | 207 (60.35%) | 94 (63.95%) |
 Dead | 136 (39.65%) | 53 (36.05%) |